Prevnar Recommendation Will Be Restored “Very Soon”
This article was originally published in The Pink Sheet Daily
Executive Summary
The Centers for Disease Control & Prevention is on track to reinstate normal dosing recommendations for the pneumococcal conjugate vaccine Prevnar in the near future, Wyeth CEO Robert Essner indicated during the Bear Stearns meeting Sept. 14.
You may also be interested in...
Prevnar Full Dose Schedule Restored By CDC
The Centers for Disease Control & Prevention reinstates four-dose recommendation for Wyeth’s pneumococcal conjugate vaccine. CDC recommended deferring the third and fourth doses earlier this year because of ongoing supply problems.
Prevnar Full Dose Schedule Restored By CDC
The Centers for Disease Control & Prevention reinstates four-dose recommendation for Wyeth’s pneumococcal conjugate vaccine. CDC recommended deferring the third and fourth doses earlier this year because of ongoing supply problems.
CDC Recommends Reinstating Third Prevnar Dose For Healthy Children
The Centers for Disease Control & Prevention states that the fourth dose of the pneumococcal conjugate vaccine should continue to be deferred until supply is adequate. Wyeth will assist physicians with a "call-back" strategy to vaccinate children who had their third dose deferred.